James Bligh - Net Worth and Insider Trading
James Bligh Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Bligh owns 1 companies in total, including Conduit Pharmaceuticals Inc (CDT) .
Click here to see the complete history of James Bligh’s form 4 insider trades.
Insider Ownership Summary of James Bligh
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDT | Conduit Pharmaceuticals Inc | 2023-09-22 | director |
James Bligh Trading Performance
James Bligh Ownership Network
James Bligh Owned Company Details
What does Conduit Pharmaceuticals Inc do?
Who are the key executives at Conduit Pharmaceuticals Inc?
James Bligh is the director of Conduit Pharmaceuticals Inc. Other key executives at Conduit Pharmaceuticals Inc include director & 10 percent owner Andrew Regan , 10 percent owner & other: See Responses Corvus Capital Ltd. , and 10 percent owner & other: See Responses Algo Holdings, Inc. .
Conduit Pharmaceuticals Inc (CDT) Insider Trades Summary
Over the past 18 months, James Bligh made no insider transaction in Conduit Pharmaceuticals Inc (CDT). Other recent insider transactions involving Conduit Pharmaceuticals Inc (CDT) include a net sale of 15,301,068 shares made by Andrew Regan ,
In summary, during the past 3 months, insiders sold 15,301,068 shares of Conduit Pharmaceuticals Inc (CDT) in total and bought 0 shares, with a net sale of 15,301,068 shares. During the past 18 months, 15,301,068 shares of Conduit Pharmaceuticals Inc (CDT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 15,301,068 shares.
Conduit Pharmaceuticals Inc (CDT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Conduit Pharmaceuticals Inc Insider Transactions
James Bligh Mailing Address
Above is the net worth, insider trading, and ownership report for James Bligh. You might contact James Bligh via mailing address: 38 Oxberry Avenue, London X0 Sw6 5ss.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
